Znn3bq.jpeg
²é¿´: 300  |  »Ø¸´: 2
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

liruihan

Ìú¸Ëľ³æ (ÕýʽдÊÖ)


[×ÊÔ´] ¡¾×ÊÔ´¡¿Cancer: Predictions in lymphoma

The presence of a specific cell type in people with lymphoma is negatively associated with survival, providing a new biomarker with potential clinical applications (Proc. Natl. Acad. Sci. USA 107, 12747¨C12754).
Jonathan Irish et al. used single-cell profiling in samples of human follicular lymphoma and found a subset of lymphoma cells with defective B cell antigen receptor (BCR) signaling. Jonathan Irish The more of these cells in each tumor, the shorter the overall subject survival. Moreover, these lymphoma cells increased in number as tumors relapsed after chemotherapy. Interestingly, BCR signaling could be reactivated in the defective cells, indicating that BCR signaling was not altogether absent but somehow suppressed.
Mechanistically, tumors with high counts of defective BCR cells had less interleukin-7 signaling in infiltrating T cells, but additional work will be required to understand how these cells emerge and what their downstream effects are.
In addition to representing a potential biomarker, the existence of cells with defective BCR signaling may provide new targets against follicular lymphoma.¡ªJCL
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lrj107hn

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)


ÕâÊÇÄÄÀïµÄ×ÊÔ´£¿
3Â¥2010-09-14 18:17:29
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 3 ¸ö»Ø´ð

liruihan

Ìú¸Ëľ³æ (ÕýʽдÊÖ)


°©Ö¢£ºÁܰÍÁöÖеÄÔ¤²âÒò×Ó
ÁܰÍÁö²¡ÈËÖÐÌØÒìϸ°ûÀàÐ͵ĴæÔÚÓ벡È˵ÄÉú´æ³Ê¸ºÏà¹Ø£¬¸Ã·¢ÏÖ¿ÉÌṩһÖÖеÄÉúÎï±ê¼ÇÎ²¢¾ßÓÐDZÔÚµÄÁÙ´²ÒâÒå¡£
ÔÚÂËÅÝÐÔÁܰÍÁöÑù±¾ÖÐʹÓõ¥Ï¸°û·ÂÐÎÇÐÏ÷¼¼Êõ·¢ÏÖÁËһЩ¾ßÓÐȱÏÝBϸ°û¿¹Ô­ÊÜÌ壨BCR£©ÐźŵÄÁܰÍÁöϸ°û¡£Ã¿¸öÖ×ÁöÖÐÕâЩϸ°ûÔ½¶à£¬²¡È˵ÄÉú´æÆÚÔ½¶Ì¡£¶øÇÒ£¬µ±»¯ÁƺóÖ×Áö¸´·¢Ê±ÕâЩÁܰÍÁöϸ°ûÊýÁ¿ÉÏÔö¼Ó¡£ÁîÈ˸ÐÐËȤµÄÊÇ£¬ÔÚÕâЩȱÏÝϸ°ûÖÐBCRÐźſÉÄÜÖØÐ»£¬ÌáʾBCRÐźŲ»ÊÇÒ»Æðȱ·¦¶øÊÇÓÐЩ±»ÒÖÖÆÁË¡£
»úÖÆÉÏ£¬°éÓнϸßÊýÁ¿È±ÏÝBCRµÄÖ×ÁöÔÚ½þÈóµÄTϸ°ûÖнÏÉÙ±í´ïIL-7Ðźţ¬µ«ÐèÒªÁíÍâµÄ¹¤×÷À´Àí½âÕâЩϸ°ûÊÇÈçºÎ³öÏֵĺÍËüÃǵÄÏÂÓÎЧӦÊÇʲô¡£
³ýÁË´ú±íDZÔÚµÄÉúÎï±ê¼ÇÎïÍ⣬°éÓÐȱÏÝBCRÐźŵÄϸ°û´æÔÚ¿ÉÌṩÂËÅÝÐÔÁܰÍÁöеİе㡣
2Â¥2010-09-14 16:35:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸085802 323·ÖÇóµ÷¼Á +12 drizzle_9 2026-04-12 13/650 2026-04-13 01:15 by ÐÒÃâ ..
[¿¼ÑÐ] ²ÄÁϹ¤³Ì281»¹Óе÷¼Á»ú»áÂð +29 xaw. 2026-04-11 30/1500 2026-04-13 00:20 by 1005715100
[¿¼ÑÐ] 305Çóµ÷¼Á +6 77Qi 2026-04-07 6/300 2026-04-12 02:30 by Çï¶¹²ËÑ¿
[¿¼ÑÐ] 331Çóµ÷¼Á +5 Íõ¹ú˧ 2026-04-11 5/250 2026-04-11 22:56 by Ϫ½§Á÷Ë®
[¿¼ÑÐ] 343Çóµ÷¼Á +9 Íõ¹ú˧ 2026-04-10 9/450 2026-04-11 20:31 by dongdian1
[¿¼ÑÐ] 11408¡£358Çóµ÷¼Á +3 TMYzds 2026-04-07 3/150 2026-04-11 17:10 by µªÆøÆøÆø
[¿¼ÑÐ] µ÷¼Á +4 µçÆø300Çóµ÷¼Á²» 2026-04-08 7/350 2026-04-11 10:44 by ×ÏêØ×ÏÆå
[¿¼ÑÐ] 085404 293Çóµ÷¼Á +9 ÓÂÔ¶¿â°®314 2026-04-06 10/500 2026-04-11 10:36 by ×ÏêØ×ÏÆå
[¿¼ÑÐ] 346£¬¹¤¿Æ0854Çóµ÷¼Á£¬×¨Ë¶ +7 moser233 2026-04-10 8/400 2026-04-11 08:52 by Öí»á·É
[¿¼ÑÐ] 291 Çóµ÷¼Á +29 »¯¹¤2026½ì±ÏÒµÉ 2026-04-09 29/1450 2026-04-10 22:55 by dick_runner
[¿¼ÑÐ] 368Çóµ÷¼Á +3 17385968172 2026-04-10 3/150 2026-04-10 20:12 by µç×Ӱµ±ë
[¿¼ÑÐ] ±¾¿ÆÎ÷¹¤´ó 324Çóµ÷¼Á +4 wysyjs25 2026-04-10 4/200 2026-04-10 20:00 by À´¿´Á÷ÐÇÓê10
[¿¼ÑÐ] 285Çóµ÷¼Á +9 AZMK 2026-04-07 11/550 2026-04-10 15:24 by AZMK
[¿¼ÑÐ] Çóµ÷¼Á +11 ôæôæÒ»ÊéÉú 2026-04-09 13/650 2026-04-10 10:27 by liuhuiying09
[¿¼ÑÐ] µ÷¼Á +12 ÔÂ@163.com 2026-04-08 12/600 2026-04-09 14:27 by rl1980
[¿¼ÑÐ] 286Çóµ÷¼Á +19 Faune 2026-04-08 20/1000 2026-04-09 08:36 by ŶŶ123
[¿¼ÑÐ] ²ÄÁϹ¤³ÌרҵÈÕÓïÉúÇóµ÷¼Á +9 111623 2026-04-07 9/450 2026-04-07 23:31 by Ò»Ö»ºÃ¹û×Ó?
[¿¼ÑÐ] 085602µ÷¼Á ³õÊÔ×Ü·Ö335 +3 19123253302 2026-04-06 3/150 2026-04-07 18:00 by jp9609
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +5 СÁõͬѧ߹߹ 2026-04-06 5/250 2026-04-06 18:34 by sherry_1901
[¿¼ÑÐ] 22408 331·ÖÇóµ÷¼Á +4 y__1 2026-04-06 4/200 2026-04-06 17:26 by ÍÁľ˶ʿÕÐÉú
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û